Zepbound was approved in November 2023 to treat patients with obesity. It was added to the national preferred formulary for Express Scripts and Cigna Healthcare in December.
Aetna, Cigna, Humana, United Healthcare — some of the largest providers of Medicare Advantage plans — have released updates to prescription drug programs.
New biosimilars have been added and others removed from CVS Caremark’s standard formulary. One notable change is with the Humira biosimilars. The PBM has removed Amjevita and now prefers Hyrimoz and an unbranded biosimilar.
Optum Rx has added more than 50 products — including both branded and generics — to the exclusion list for the 2024 Premium Formulary.
Medicare will cover Alzheimer’s drugs with full approval, including Leqembi — if the physician and patient participate in a real-world registry trial to gather additional data.